BioCision LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioCision LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10857
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company provides products such as cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell thawing systems, sample and snap cooling and freezing systems, support platforms, sample transport systems, and others. It offers other products such as insulated tote bags, cryostorage boxes, cryopreservation accessories, faucet adaptors, ice pans and buckets, cryogenic vial racks, and other accessories. BioCision provides services such as cell preparation, cell thawing, cell transport and storage, cell freezing, stem cell cryopreservation, cell therapy processes, PBMC processing, and biobanking sample handling and transport services, among others. The company caters researchers, clinicians and manufacturers to protect temperature sensitive therapeutics, biological samples and biomaterials, among others. It operates in San Rafael and Menlo Park, the US. BioCision is headquartered in San Rafael, California, the US.

BioCision LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioCision LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioCision LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioCision LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioCision LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
BioCision Raises US$2.5 Million In Growth Financing 11
Partnerships 13
BioCision Partners with University of California 13
BioCision Enters into Co-Development Agreement with Celgene Cellular Therapeutics 14
BioCision Enters into Co-Development Agreement with Brooks Automation 15
BioCision Enters Into Co-Development Agreement With ATCC 16
Acquisition 17
Brooks Automation Invests US$4 Million In BioCision 17
BioCision LLC – Key Competitors 18
BioCision LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BioCision LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioCision LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioCision LLC, Deals By Therapy Area, 2012 to YTD 2018 8
BioCision LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioCision LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioCision Raises US$2.5 Million In Growth Financing 11
BioCision Partners with University of California 13
BioCision Enters into Co-Development Agreement with Celgene Cellular Therapeutics 14
BioCision Enters into Co-Development Agreement with Brooks Automation 15
BioCision Enters Into Co-Development Agreement With ATCC 16
Brooks Automation Invests US$4 Million In BioCision 17
BioCision LLC, Key Competitors 18

List of Figures
BioCision LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioCision LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioCision LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioCision LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioCision LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alere Inc. (ALR):(医療機器分野)企業M&A及び提携動向
    Summary Alere Inc. (Alere), (formerly Inverness Medical Innovations, Inc.) is one of the leading providers of point-of-care diagnostics solutions and services. Its solutions and services enable patients to take charge of their own health at home and allow healthcare providers and payors to enhance c …
  • Alcon Laboratories, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Alcon Laboratories, Inc. (Alcon Lab) is a medical device company. The company develops, manufactures and markets surgical equipment and devices, pharmaceuticals and vision care products. Its product categories include contact lenses and care, prescription pharmaceuticals, surgical products, …
  • Izocam Ticaret ve Sanayi A.S.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Izocam Ticaret ve Sanayi A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stri …
  • Xcel Energy Inc (XEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Otonomy Inc (OTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The company’s Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for …
  • Showa Shell Sekiyu K.K. (5002):企業のM&A・提携動向(エネルギー分野)
    Summary Showa Shell Sekiyu K.K. (Showa Shell) is an independent energy company, which carries out crude oil procurement, refining and sale of refined oil products. It also sells propane gas, lubricants and electricity. Its product portfolio includes gasoline, diesel, heavy oil, xylene, benzene, prop …
  • Myers Industries, Inc. (MYE):企業概要、財務及び戦略的SWOT分析
    Summary Myers Industries, Inc. (Myers) is a polymer product manufacturer. The company manufactures polymer products for material handling. It distributes a comprehensive line of rubber tire repair plugs, patches and chemicals, and other specialty products. Myers markets polymer product for agricultu …
  • Nihon Unisys, Ltd. (8056):企業の財務及び戦略的SWOT分析
    Summary Nihon Unisys, Ltd. (Unisys) is a technology company that offers technology services, IT outsourcing services, support and system-related services, and system integration services. The company provides enterprise resource planning, supplier relationship management, customer relationship manag …
  • Samson Oil & Gas Limited (SSN):企業のM&A・提携動向(石油・ガス分野)
    Summary Samson Oil & Gas Limited (Samson) is an oil and gas company that offers exploration and production of crude oil and natural gas reserves. The company’s oil and gas projects comprise Goshen County, Sweetwater County, Williams County, Renville and Ward Counties; Roosevelt County, Lea County, a …
  • Newrest Group International S.A.S:企業概要およびSWOT分析
    Summary Canadean's "Newrest Group International S.A.S: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, c …
  • Posco Chemtech Company Ltd.:企業の戦略・SWOT・財務分析
    SummaryPosco Chemtech Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Layne Christensen Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Layne Christensen Company Merge …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Drugs for Neglected Diseases initiative(製薬・医療分野):企業M&A動向
    Summary Drugs for Neglected Diseases initiative (DNDi) is a drug discovery company. The company develops therapeutics for the treatment of various diseases. Its products include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi’s ASAQ is a fixed dose combination of artesunate and amodiaquine …
  • PT. BNI Life Insurance:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "PT. BNI Life Insurance" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fo …
  • Safety-Kleen Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Safety-Kleen Systems, Inc. Merg …
  • Daily Polymer Corporation (4716):企業概要、財務及び戦略的SWOT分析
    Summary Daily Polymer Corporation (Daily Polymer) is a chemical product manufacturing company. The company produces and markets synthetic resin for paints and adhesives. It offers polymer materials, photo-electronic materials and conductive polymers such as unsaturated polyester resins, solvent type …
  • BioPorto Diagnostics A/S (formerly AntibodyShop A/S):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioPorto Diagnostics A/S (forme …
  • Immucor, Inc.:企業の戦略的SWOT分析
    Immucor, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Centre of Excellence for Prevention of Organ Failure:企業のM&A・提携動向(医療機器分野)
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that develops and markets blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease, such as …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆